NasdaqCM - Nasdaq Real Time Price
USD
Akanda Corp. (AKAN)
3.3500
-0.3200
(-8.72%)
At close: September 4 at 4:00:01 PM EDT
3.4100
+0.0600
(+1.79%)
After hours: September 4 at 7:59:48 PM EDT
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Ms. Katharyn Field
|
Interim CEO & Executive Director | 96k | -- | 1983 |
|
Dr. Gurcharn Deol B.A., M.A., Ph.D.
|
Chief Financial Officer | 27.05k | -- | 1968 |
|
Mr. Edgar Contreras
|
Country Manager of First Towers | 34.91k | -- | 1974 |
|
Mr. Francisco Juarez
|
VP, COO & Director of First Towers | 19.33k | -- | 1979 |
Akanda Corp.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Corporate Governance
Akanda Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 1, 2026 at 12:00 AM UTC
NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
